Status:

COMPLETED

Sleep Disorders and Gastroesophageal Reflux Disease (GERD)

Lead Sponsor:

University of North Carolina

Collaborating Sponsors:

Janssen Pharmaceutica N.V., Belgium

Conditions:

Insomnia

GERD

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

This study will investigate Gastroesophageal Reflux Disease (GERD)as a cause of sleep disturbance. Patients with GERD may experience all or some of the following symptoms: stomach acid or partially di...

Detailed Description

Participants with known insomnia will undergo an overnight pH and sleep study. Those found to be eligible after the first sleep study (those with significantly poor sleep quality and no significant sl...

Eligibility Criteria

Inclusion

  • English-speaking male or female subjects, 18-75 years of age. (Women must be two (2) years post-menopausal or surgically sterile. Women of childbearing potential or \<1 year post-menopausal must be practicing an approved method of contraception and have a negative urine pregnancy test at screening.),
  • a six-month duration of insomnia,
  • sleep difficulty at least 3 nights per week, and a sleep study demonstrating \> 10 arousals/hour for those aged \< 45, and \>15 for those who are 45 or older.

Exclusion

  • BMI \> 30 or history of snoring (in order to decrease the prevalence of sleep apnea in the sample),
  • use of any proton pump inhibitor or H2 receptor antagonist within one week of undergoing initial sleep study,
  • previous acid-suppressing medication for sleep disturbances,
  • previous surgical antireflux procedure,
  • current medical therapy that includes digoxin or ketoconazole,
  • previous aerodigestive malignancy,
  • a previously diagnosed psychological or medical cause of insomnia (other than suspected GERD), and
  • inability or unwillingness to provide consent for the procedures.

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

End Date :

December 1 2006

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00287391

Start Date

September 1 2004

End Date

December 1 2006

Last Update

April 27 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UNC Gastroenterology and UNC Sleep Disorders Center

Chapel Hill, North Carolina, United States, 27599